Neuropathology of incidental Lewy body & prodromal Parkinson’s disease

Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, et al. Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson’s disease. Mov Disord. 2014;29:454–62.

Article  PubMed  PubMed Central  Google Scholar 

Hornykiewicz O. Dopamine miracle: from brain homogenate to dopamine replacement. Mov Disord. 2002;17:501–8.

Article  PubMed  Google Scholar 

Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Bank NB, Rozemuller AJM, et al. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson’s disease. Mov Disord. 2014;29:1244–51.

Article  PubMed  Google Scholar 

Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839–40.

Article  CAS  PubMed  Google Scholar 

Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat Neurosci. 2019;22:1099–109.

Article  CAS  PubMed  Google Scholar 

Chartier-Harlin MC, Chartier-Harlin M-C, Kachergus J, Kachergus J, Roumier C, Roumier C, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet. 2004;364:1167–9.

Article  CAS  PubMed  Google Scholar 

Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat Genet. 1998;18:106–8.

Article  PubMed  Google Scholar 

Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science (New York, NY). 1997;276:2045–7.

Article  CAS  Google Scholar 

Papapetropoulos S, Adi N, Ellul J, Argyriou AA, Chroni E. A Prospective study of familial versus sporadic Parkinson’s disease. Neurodegener Dis. 2007;4:424–7.

Article  PubMed  Google Scholar 

Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet. 2014;46:989–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braak H, Tredici KD. neuropathological staging of brain pathology in sporadic Parkinson’s disease: separating the wheat from the chaff. J Park Dis. 2017;7:S73-87.

Google Scholar 

Goedert M, Spillantini MG, Tredici KD, Braak H. 100 years of Lewy pathology. 2013.

Book  Google Scholar 

Braak H, Braak H, Tredici KD, Tredici KD. Neuroanatomy and pathology of sporadic Parkinson’s disease. Adv Anat Embryol Cell Biol. 2009;201:1–119.

PubMed  Google Scholar 

Jellinger KA. Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I Hypokinetic-rigid movement disorders. J Neural Transm. 2019;126:933–95.

Article  PubMed  Google Scholar 

Sian-Hulsmann J, Monoranu C, Strobel S, Riederer P. Lewy bodies: a spectator or salient killer? Cns Neurol Disord Drug Targets. 2015;14:947–55.

Article  CAS  PubMed  Google Scholar 

van de Berg WDJ, Hepp DH, Dijkstra AA, Rozemuller JAM, Berendse HW, Foncke E. Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson’s disease. Parkinsonism Relat D. 2012;18:S28-30.

Article  Google Scholar 

Braak H, Tredici KD, Rüb U, de Vos RAI, Steur ENHJ, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.

Article  PubMed  Google Scholar 

Braak H, Ghebremedhin E, Rüb U, Bratzke H, Tredici KD. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318:121–34.

Article  PubMed  Google Scholar 

Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 2009;117:613–34.

Article  PubMed  PubMed Central  Google Scholar 

Li J-Y, Li JY, Englund E, Englund E, Holton JL, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat Med. 2008;14:501–3.

Article  CAS  PubMed  Google Scholar 

Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat Med. 2008;14:504–6.

Article  CAS  PubMed  Google Scholar 

Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ, et al. Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease. J Exp Med. 2016;213:1759–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science (New York, NY). 2012;338:949–53.

Article  CAS  Google Scholar 

Peelaerts W, Bousset L, der Perren AV, Moskalyuk A, Pulizzi R, Giugliano M, et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015;522:340–4.

Article  CAS  PubMed  Google Scholar 

Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, et al. Prion-like spreading of pathological α-synuclein in brain. Brain. 2013;136:1128–38.

Article  PubMed  PubMed Central  Google Scholar 

Recasens A, Dehay B, Bové J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, et al. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol. 2014;75:351–62.

Article  CAS  PubMed  Google Scholar 

Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, et al. Propagation of pathological α-synuclein in marmoset brain. Acta Neuropathol Commun. 2017;5:12.

Article  PubMed  PubMed Central  Google Scholar 

Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51:745–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jellinger KA. A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol. 2008;116:1–16.

Article  CAS  PubMed  Google Scholar 

Parkkinen L, Pirttilä T, Alafuzoff I. Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance. Acta Neuropathol. 2008;115:399–407.

Article  PubMed  PubMed Central  Google Scholar 

Ansorge O, Daniel SE, Pearce RK. Neuronal loss and plasticity in the supraoptic nucleus in Parkinson’s disease. Neurology. 1997;49:610–3.

Article  CAS  PubMed  Google Scholar 

MacDonald V, Halliday GM. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson’s disease. Mov Disord. 2002;17:1166–73.

Article  PubMed  Google Scholar 

Pedersen KM, Marner L, Pakkenberg H, Pakkenberg B. No global loss of neocortical neurons in Parkinson’s disease: a quantitative stereological study. Mov Disord. 2005;20:164–71.

Article  PubMed  Google Scholar 

Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson’s disease. Ann Neurol. 1990;27:373–85.

Article  CAS  PubMed  Google Scholar 

Thannickal TC, Lai Y-Y, Siegel JM. Hypocretin (orexin) cell loss in Parkinson’s disease. Brain. 2007;130:1586–95.

Article  PubMed  Google Scholar 

Kremer HP, Bots GT. Lewy bodies in the lateral hypothalamus: do they imply neuronal loss? Mov Disord. 1993;8:315–20.

Article  CAS  PubMed  Google Scholar 

Iacono D, Geraci-Erck M, Rabin ML, Adler CH, Serrano G, Beach TG, et al. Parkinson disease and incidental Lewy body disease: just a question of time? Neurology. 2015;85:1670–9.

Article  PubMed  PubMed Central  Google Scholar 

Schneider SA, Alcalay RN. Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord. 2017;32:1504–23.

Article  PubMed  PubMed Central  Google Scholar 

Kalia LV, Lang AE, Hazrati L-N, Fujioka S, Wszolek ZK, Dickson DW, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 2015;72:100–5.

Article  PubMed  PubMed Central 

留言 (0)

沒有登入
gif